Investor Relations

This section of the Co-Diagnostics InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Co-Diagnosticsassumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQCODX
Beta(1.15)
Shares Outstanding34.0M
Average Volume (10 days)442.4K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)$1.30
Sales (TTM)$2.15
Book Value (MRQ)$4.35
Cash Flow (TTM)$1.18
Cash (MRQ)$2.87

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy2
 
Buy0
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Brian L. Brown
Chief Financial Officer
(7,869)
Dispose
May 23, 2022
Brian L. Brown
Chief Financial Officer
21,666
Acquire
May 23, 2022
Dwight H Egan
Director, Chief Executive Officer
33,334
Acquire
May 23, 2022
Dwight H Egan
Director, Chief Executive Officer
(11,854)
Dispose
May 23, 2022
Eugene Durenard
Director
12,500
Acquire
Jan 8, 2022

Recent SEC Filings

Company Events
Jun 16, 2022
Insider Buy/Sell
Jun 7, 2022
Insider Buy/Sell
Jun 7, 2022
Insider Buy/Sell
May 25, 2022
Insider Buy/Sell
May 25, 2022